Cisplatin shows limited therapeutic efficacy due to serious side effects such as nephrotoxicity and hepatotoxicity. In the present study, we demonstrate that 1,2,3,4,6-penta-O-galloyl-β-d-glucose (
PGG) has protective effects against
cisplatin-induced cytotoxicity and apoptosis in normal human primary renal epithelial cells (HRCs) while showing synergistic effect against
cisplatin-induced cell death in human Caki-2
renal cancer cells.
PGG significantly blocked
cisplatin-mediated cytotoxicity and reduced
cisplatin-induced sub-G1 accumulation in HRCs. Consistently,
PGG reduced the number of apoptotic cell populations by TdT-mediated dUTP nick end labeling (TUNEL) and Live/Dead assays in
cisplatin-treated HRCs. Furthermore,
PGG suppressed PARP cleavage and
caspase-3 activation,
cytochrome c release, up-regulation of bax and p53 in
cisplatin-treated HRCs. Moreover,
PGG attenuated
reactive oxygen species (ROS) production mediated by
cisplatin treatment, suggesting that
PGG prevented
cisplatin-induced apoptosis by inhibiting ROS generation in HRCs. Notably,
PGG significantly enhanced cytotoxicity and PARP cleavage in
cisplatin-treated Caki-2
renal cancer cells. Combination Index (CI) revealed synergism between
PGG and
cisplatin in Caki-2 cells. Taken together, our findings suggest the dual effects of
PGG as a protective supplement against
cisplatin-induced toxicity in normal renal cells and a combination chemotherapeutic
drug with
cisplatin in
renal cancer cells.